.: CONVERG MEDICAL CORPORATION :.

EpiFLO^® Clinical Research & Highlights

$C:\Users\Owner\Pictures\ist2_3857179_filling_out_medical_document.jpg$

HOME > ENG : Cinical Research Highlights

Come Back to see more results. EpiFLO^® is currently being tested in RCTs (Randomized Clinical Trials.) Please return to see more Evidence Based Medicine.

Clinical Research Poster Presentations (EpiFLO^® studies)

Continuous Local Oxygen Delivery Promotes Wound Healing
- presented at the Symposium on Advanced Wound Care, Las Vegas, NV

Amputation Date Cancelled Due to the Use of Transdermal Sustained Oxygen Therapy in the Healing of a Diabetic Foot Ulcer with Osteomyelitis
- presented at the American Professional Wound Care Association, Philadelphia, PA
Transdermal Sustained Oxygen Therapy for Chronic Wound Care Management
– presented at the Canadian Association of Wound Care , London ON November 2007

Recent Clinical Journal Publications (EpiFLO^® studies)

Said, H.K. et al. Transdermal Sustained-delivery oxygen improves epithelial healing in a rabbit ear wound model Arch Surg, 2005, October 140(10): 998-1004
Wilson, C. et al. J. Wound, Ostomy & Continence Nursing, 2005, 32(3S): Supplement 2: S6

Publications and Presentations supporting Topical Oxygen

Scott GF, Reeves RE. Topical Oxygen Alters Angiogenesis-related Growth Factor Expression in Chronic Diabetic Foot Ulcers. Presented at: New Cardiovascular Horizons; Oct 01, 2005; Fort Worth, Texas.

Development : SimpleMedia.ca